Drug recall · April 13, 2022
Risedronate Sodium Tablets recall
Why: FAILED CONTENT UNIFORMITY SPECIFICATIONS
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.
- Lots / codes
Lot #: BRD2001A, Exp 5/2022
- Quantity
- 4872 bottles
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- USA Nationwide
- Initiated
- March 10, 2022 · Voluntary: Firm initiated
- Classified
- April 7, 2022
- Reported
- April 13, 2022
- Ended
- June 29, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Risedronate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.